1. Home
  2. ASLN

ASLN

ASLAN Pharmaceuticals Limited

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.

Founded: 2010 Country:
Singapore
Singapore
Employees: N/A City: N/A
Market Cap: 12.0M IPO Year: 2018
Target Price: $11.33 AVG Volume (30 days): 1.0M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.75 EPS Growth: N/A
52 Week Low/High: $0.39 - $4.69 Next Earning Date: 04-12-2024
Revenue: $12,000,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: